{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:58:53Z","timestamp":1790747933493,"version":"4.1.0"},"reference-count":33,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Science Progress"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We evaluated whether admission Galectin-3 (Gal-3) was associated with higher apparent discrimination and reclassification when added to the TIMI, HEART and GRACE scores for 12-month major adverse cardiovascular events (MACE) in Vietnamese patients with acute coronary syndrome (ACS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective observational cohort included 103 adults with ACS diagnosed according to the 2023 European Society of Cardiology criteria between August 2024 and April 2025. Patients were followed for 12 months, with final follow-up completed in April 2026. Serum Gal-3 was measured at admission. The primary endpoint was MACE, comprising all-cause death, nonfatal myocardial infarction, nonfatal stroke, unplanned hospitalization for heart failure or unplanned coronary revascularization. Discrimination of the TIMI, HEART and GRACE scores, with and without Gal-3, was assessed by area under the receiver operating characteristic curve (AUC). Reclassification was evaluated using continuous net reclassification improvement (NRI) and integrated discrimination improvement (IDI), with 95% confidence intervals estimated from 1,000 bootstrap resamples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During follow-up, 16 patients (15.5%) experienced MACE. Admission Gal-3 was higher in patients with MACE than in those without MACE (median 28.7 vs 15.4 ng\/mL) and the adjusted median difference remained significant (p=0.034). Adding Gal-3 yielded higher apparent AUCs for TIMI (0.584 vs 0.804), HEART (0.580 vs 0.802) and GRACE (0.620 vs 0.797), with optimism-corrected AUCs of 0.785, 0.789 and 0.783, respectively. Given the limited number of outcome events, these estimates remain exploratory and potentially optimistic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Higher admission Gal-3 levels were associated with 12-month MACE. Adding Gal-3 to established risk scores yielded higher apparent discrimination and secondary exploratory reclassification metrics; however, the magnitude of these differences remains uncertain and may still be optimistic despite bootstrap correction. These analyses should be regarded as hypothesis-generating rather than as the development of candidate clinical prediction models, and external validation in larger multicenter cohorts is required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/00368504261490436","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:30:29Z","timestamp":1789727429000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Galectin-3\u2013enhanced prognostic models for major adverse cardiovascular events in Vietnamese patients with acute coronary syndrome: A prospective cohort study"],"prefix":"10.1177","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4623-7033","authenticated-orcid":false,"given":"Bao The","family":"Nguyen","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Medicine and Pharmacy"},{"name":"Hue University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pham Van","family":"Do","sequence":"additional","affiliation":[{"name":"Department of Intensive Care and Toxicology, Hoan My Cuu Long Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoa Thai","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Can Tho University of Medicine and Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhung Hong Thi","family":"Thai","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Can Tho University of Medicine and Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung Ich","family":"Ly","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology, Cho Ray Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6629-6954","authenticated-orcid":false,"given":"An Viet","family":"Tran","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Can Tho University of Medicine and Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"e_1_3_8_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/2048872620974612"},{"key":"e_1_3_8_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30597-w"},{"key":"e_1_3_8_4_2","first-page":"200458","article-title":"Prognostic value of RS1333040 polymorphism in the ANRIL gene for coronary artery lesions and cardiovascular events in acute myocardial infarction patients","volume":"26","author":"Ngoc Pham NT","year":"2025","unstructured":"Ngoc Pham NT, Thao Tran LN, Trung CH, et al. Prognostic value of RS1333040 polymorphism in the ANRIL gene for coronary artery lesions and cardiovascular events in acute myocardial infarction patients. Int J Cardiol Cardiovasc Risk Prev 2025; 26: 200458. https:\/\/doi.org\/10.1016\/j.ijcrp.2025.200458","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"e_1_3_8_5_2","unstructured":"World Health Organization. Cardiovascular diseases (CVD) in Viet Nam. https:\/\/www.who.int\/vietnam\/health-topics\/cardiovascular-diseases accessed 20 October 2025."},{"key":"e_1_3_8_6_2","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47050332"},{"key":"e_1_3_8_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-025-00764-x"},{"key":"e_1_3_8_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.159160"},{"key":"e_1_3_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.02.046"},{"key":"e_1_3_8_10_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2013.206185"},{"key":"e_1_3_8_11_2","doi-asserted-by":"publisher","DOI":"10.26599\/1671-5411.2025.07.001"},{"key":"e_1_3_8_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad191"},{"key":"e_1_3_8_13_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.818162"},{"key":"e_1_3_8_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780010204"},{"key":"e_1_3_8_15_2","first-page":"770","article-title":"Association of galectin-3 and soluble ST2 with in-hospital and 1-year outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"129","author":"Tymi\u0144ska A","year":"2019","unstructured":"Tymi\u0144ska A, Kap\u0142on-Cie\u015blicka A, Oziera\u0144ski K, et al. Association of galectin-3 and soluble ST2 with in-hospital and 1-year outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Pol Arch Intern Med 2019; 129: 770\u2013780. https:\/\/doi.org\/10.20452\/pamw.15030","journal-title":"Pol Arch Intern Med"},{"key":"e_1_3_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjnut.2024.04.016"},{"key":"e_1_3_8_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.7.835"},{"key":"e_1_3_8_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.17.2031"},{"key":"e_1_3_8_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03086144"},{"key":"e_1_3_8_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.19.2345"},{"key":"e_1_3_8_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-021-01440-5"},{"key":"e_1_3_8_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.033502"},{"key":"e_1_3_8_23_2","doi-asserted-by":"publisher","DOI":"10.32614\/R.manuals"},{"key":"e_1_3_8_24_2","first-page":"55","article-title":"Thinking beyond the mean: a practical guide for using quantile regression methods for health services research","volume":"25","author":"L\u00ea Cook B","year":"2013","unstructured":"L\u00ea Cook B, Manning WG. Thinking beyond the mean: a practical guide for using quantile regression methods for health services research. Shanghai Arch Psychiatry 2013; 25: 55\u201359. https:\/\/doi.org\/10.3969\/j.issn.1002-0829.2013.01.011","journal-title":"Shanghai Arch Psychiatry"},{"key":"e_1_3_8_25_2","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1176348524"},{"key":"e_1_3_8_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4348"},{"key":"e_1_3_8_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000000018"},{"key":"e_1_3_8_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(03)00047-7"},{"key":"e_1_3_8_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1466-7"},{"key":"e_1_3_8_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(01)00341-9"},{"key":"e_1_3_8_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.8281"},{"key":"e_1_3_8_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378"},{"key":"e_1_3_8_33_2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13213348"},{"key":"e_1_3_8_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12855"}],"container-title":["Science Progress"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00368504261490436","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00368504261490436","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00368504261490436","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:17:23Z","timestamp":1790745443000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00368504261490436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1177\/00368504261490436"],"URL":"https:\/\/doi.org\/10.1177\/00368504261490436","relation":{},"ISSN":["0036-8504","2047-7163"],"issn-type":[{"value":"0036-8504","type":"print"},{"value":"2047-7163","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"article-number":"00368504261490436"}}